Ribavirin enhances osteoclast formation through osteoblasts via up-regulation of TRANCE/RANKL
Authors:
- 15 August 2006
- journal article
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 296 (1-2) , 17-24
Abstract
Hepatitis C combination therapy comprising ribavirin and interferon-α causes dramatic improvement with the sustained virological response; however, this treatment may result in the loss of bone mineral density. To investigate the effects of ribavirin on bone cells, we examined osteoblast differentiation as well as the formation of osteoclasts from their precursors. Ribavirin enhances osteoclast formation through osteoblasts by up-regulation of TRANCE/RANKL gene expression, whereas it has no significant effect on either osteoblast differentiation or on bone formation. Understanding ribavirin’s underlying mechanism of action on bone cells will enable the improved management of bone loss in chronic hepatitis C patients.Keywords
This publication has 19 references indexed in Scilit:
- Nuclear Factor of Activated T Cells c1 Induces Osteoclast-associated Receptor Gene Expression during Tumor Necrosis Factor-related Activation-induced Cytokine-mediated OsteoclastogenesisJournal of Biological Chemistry, 2005
- Ribavirin, but Not Interferon α-2b, is Associated with Impaired Osteoblast Proliferation and Differentiation In VitroCalcified Tissue International, 2004
- Microphthalmia Transcription Factor and PU.1 Synergistically Induce the Leukocyte Receptor Osteoclast-associated Receptor Gene ExpressionJournal of Biological Chemistry, 2003
- Lack of evidence for ribavirin-induced bone lossHepatology, 2002
- Peginterferon Alfa-2a in Patients with Chronic Hepatitis CNew England Journal of Medicine, 2000
- Bone mineral density, serum insulin-like growth factor I, and bone turnover markers in viral cirrhosisHepatology, 1998
- [20] Role of 1α,25-dihydroxyvitamin D3 in osteoclast differentiation and function1997
- Successful treatment of osteoporosis in systemic mastocytosis with interferon alpha-2bAnnals of Hematology, 1996
- Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis.Journal of Experimental Medicine, 1994
- Treatment of Chronic Non-A, Non-B Hepatitis with Recombinant Human Alpha InterferonNew England Journal of Medicine, 1986